Search Results 121-130 of 18698 for amyloidosis
Study of Dexamethasone Plus IXAZOMIB or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis · Overview · Participation ...
... amyloidosis who have had a hematologic response to previous treatment for their amyloidosis (e.g., chemotherapy, autologous stem cell transplant [ASCT]) and ...
... amyloidosis An expansion component in up to 2 anticipated PRX004 RP2D cohorts selected from dose escalation (up to an additional 3 subjects in each expanded ...
Some people with amyloidosis may need a liver transplant or a heart-liver transplant. Doctors also treat hyperoxaluria, a condition in which you have too much ...
The purpose of this study is to provide expanded access of patisiran to patients with hereditary transthyretin-mediated amyloidosis (hATTR). Participation ...
The patients that will be treated with STI-6129 in this trial are relapsed or refractory systemic AL amyloidosis patients who have received prior lines of ...
The Blood and Marrow Transplant Research Program at Mayo Clinic is a leader in GVHD, stem cell transplant, immune therapies, amyloidosis and POEMS syndrome.
... amyloidosis involving the peripheral nerves and compare these results to non-amyloid diseased controls. Participation eligibility. Participant eligibility ...
The purpose of this study is to evaluate the effectiveness and safety of vutrisiran (ALN-TTRSC02) in patients with hereditary transthyretin amyloidosis (hATTR ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!